Trials / Completed
CompletedNCT02193048
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 216 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to prospectively evaluate a scoring system to predict a mild course of disease in patients newly diagnosed with Crohn's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This study will evaluate a new clinical scoring system in patients receiving routine treatment | Treatment for Crohn's disease will be performed routinely based on the treating physicians clinical determination and patients' needs. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2014-07-17
- Last updated
- 2024-05-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02193048. Inclusion in this directory is not an endorsement.